| Noncolorectal Gastrointestinal Cancer |
1 |
1 |
| Otolaryngology |
0 |
0.77 |
| Esophageal Cancer |
0 |
0.76 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.75 |
| Biologic Therapy |
0 |
0.74 |
| Leukemia |
0 |
0.65 |
| Cancer |
0 |
0.62 |
| Esophageal Lymphoma |
0 |
0.56 |
| Lymphoma |
0 |
0.52 |
| Follicular Lymphoma |
0 |
0.44 |
| Hodgkin Lymphoma |
0 |
0.42 |
| B-Cell Lymphoma |
0 |
0.4 |
| Genomic Medicine |
0 |
0.4 |
| Esophagus |
0 |
0.34 |
| Chronic Lymphocytic Leukemia |
0 |
0.29 |
| Acute Leukemia |
0 |
0.24 |
| Chronic Myelogenous Leukemia |
0 |
0.24 |
| Acute Lymphoblastic Leukemia |
0 |
0.23 |
| Chemotherapy |
0 |
0.17 |
| Combination Chemotherapy |
0 |
0.17 |
| Refractory |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Clinical Research |
0 |
0.12 |
| Gastroesophageal Reflux Disease |
0 |
0.12 |
| Immunomodulator |
0 |
0.1 |
| Barrett Esophagus |
0 |
0.08 |
| Endoscopy |
0 |
0.07 |
| Immunotherapy |
0 |
0.07 |
| Monoclonal Antibody |
0 |
0.07 |
| Steroids |
0 |
0.07 |